Correlation Between Co Diagnostics and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Co Diagnostics and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Co Diagnostics and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Co Diagnostics and Novavax, you can compare the effects of market volatilities on Co Diagnostics and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Co Diagnostics with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Co Diagnostics and Novavax.

Diversification Opportunities for Co Diagnostics and Novavax

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between CODX and Novavax is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Co Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Co Diagnostics are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Co Diagnostics i.e., Co Diagnostics and Novavax go up and down completely randomly.

Pair Corralation between Co Diagnostics and Novavax

Given the investment horizon of 90 days Co Diagnostics is expected to under-perform the Novavax. In addition to that, Co Diagnostics is 1.42 times more volatile than Novavax. It trades about -0.16 of its total potential returns per unit of risk. Novavax is currently generating about -0.02 per unit of volatility. If you would invest  793.00  in Novavax on December 28, 2024 and sell it today you would lose (93.00) from holding Novavax or give up 11.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Co Diagnostics  vs.  Novavax

 Performance 
       Timeline  
Co Diagnostics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Novavax 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Novavax is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Co Diagnostics and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Co Diagnostics and Novavax

The main advantage of trading using opposite Co Diagnostics and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Co Diagnostics position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Co Diagnostics and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA